Equities

Aptamer Group PLC

APTA:LSE

Aptamer Group PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.925
  • Today's Change-0.025 / -2.63%
  • Shares traded2.75m
  • 1 Year change131.25%
  • Beta1.3393
Data delayed at least 20 minutes, as of Feb 06 2026 16:14 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Aptamer Group plc is a United Kingdom-based global developer of aptamer-based ligands. The Company develops custom affinity binders through its Optimer platform to enable new approaches in therapeutics, diagnostics and research applications. The Company's Optimer platform delivers aptamer tools that are enabling researchers and developers across the spectrum of the life sciences. Its Optimer binders have been developed for a range of applications, including therapeutic inhibitors and modulators, drug delivery vehicles, protein purification and separation, biomarker screening and validation, in vitro research, quality control analysis, pharmacokinetic and drug assays, and in vitro diagnostic assays. Its Aptamer Diagnostics division uses the Company's technology to support the development of diagnostic platforms, such as proteomics, lateral flow devices, biosensors and immunoassays, such as enzyme-linked immunosorbent assay (ELISA).

  • Revenue in GBP (TTM)1.20m
  • Net income in GBP-2.42m
  • Incorporated2014
  • Employees31.00
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Proteome Sciences plc4.53m-3.33m6.21m36.006.21m36.00
Rua Life Sciences PLC5.17m-850.00k9.00m33.009.00m33.00
Verici DX PLC1.41m-5.60m10.90m15.0010.90m15.00
Genedrive PLC954.00k-5.23m11.84m43.0011.84m43.00
Cellbxhealth PLC2.62m-15.78m11.96m119.0011.96m119.00
Abingdon Health PLC8.43m-3.42m15.06m121.0015.06m121.00
Inspiration Healthcare Group PLC45.20m-11.44m15.24m214.0015.24m214.00
Aptamer Group PLC1.20m-2.42m24.95m31.0024.95m31.00
Renalytix PLC2.20m-14.99m25.19m45.0025.19m45.00
Aoti Inc46.93m1.73m44.40m80.0044.40m80.00
Ondine Biomedical Inc1.18m-12.84m46.47m43.0046.47m43.00
Inspecs Group PLC192.83m-3.31m71.17m1.65k71.17m1.65k
Creo Medical Group PLC2.20m12.60m73.21m133.0073.21m133.00
Data as of Feb 06 2026. Currency figures normalised to Aptamer Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

10.99%Per cent of shares held by top holders
HolderShares% Held
Oberon Investments Ltd. (GB Investment Management)as of 04 Aug 2025172.05m6.38%
CRUX Asset Management Ltd.as of 03 Oct 2024100.00m3.71%
Lansdowne Partners (UK) LLPas of 20 Aug 202424.34m0.90%
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.